ResApp Health recently announced its planned sale to Pfizer Australia, a wholly owned subsidiary of Pfizer Inc. Pfizer agrees it would acquire 100% of the shares for AUD $0.115 / share,.
Digital health company ResApp has entered into a binding scheme of arrangement with Pfizer, in a deal worth $100 million. Firm: DLA Piper (ResApp Health Limited). Deal: DLA Piper have advised ResAp
Testing is one of the pillars of public health needed to control the spread of COVID. But if it is too difficult for most people to do, it doesn t get done. New methods may soon make it easier.